Identification of the crucial parameters regarding the efficacy of ribavirin therapy in Crimean–Congo haemorrhagic fever (CCHF) patients: a systematic review and meta-analysis
Objectives
Recently, ribavirin has been suggested as a therapeutic approach in Crimean–Congo haemorrhagic fever (CCHF) patients; however, there are controversial findings about its efficacy. In the current study, a meta-analysis was systematically performed to assess the effectiveness of ribavirin administration regarding CCHF patient survival and to explore the most important influential parameters for its efficacy.
Methods
All of the outcomes of the clinically studied CCHF patients who were treated with ribavirin were included in the meta-analysis.
Results
Overall, 24 studies met our criteria. Although the studies did not have high quality there was no heterogeneity and publication bias across studies. The results indicated that the administration of ribavirin to CCHF patients significantly decreased the mortality rate (by 1.7-fold) compared with those who did not receive this medication. Furthermore, it was found that the prescription of ribavirin in the initial phase of disease was more effective, and a delay in the start of treatment resulted in a 1.6-fold increase in mortality rate. In addition, interventional therapy resulted in an ∼2.3-fold reduction in the mortality rate of those who received ribavirin along with corticosteroids compared with those who were treated with ribavirin monotherapy.
Conclusions
This meta-analysis reveals that ribavirin should be considered as a crucial antiviral drug in the therapeutic approach used for CCHF patients, especially in early phases of the disease. Additionally, it seems that the administration of corticosteroids alongside ribavirin can play an effective role in alleviation of the disease status, particularly in haemorrhagic phases.
Топ-30
Журналы
|
1
2
|
|
|
PLoS Neglected Tropical Diseases
2 публикации, 6.9%
|
|
|
Infection and Drug Resistance
2 публикации, 6.9%
|
|
|
Journal of Vector Borne Diseases
2 публикации, 6.9%
|
|
|
Nature Reviews Microbiology
1 публикация, 3.45%
|
|
|
Frontiers in Immunology
1 публикация, 3.45%
|
|
|
Infectious Diseases and Therapy
1 публикация, 3.45%
|
|
|
Comparative Immunology, Microbiology and Infectious Diseases
1 публикация, 3.45%
|
|
|
Molecular and Cellular Probes
1 публикация, 3.45%
|
|
|
Pathogens
1 публикация, 3.45%
|
|
|
Nucleosides, Nucleotides and Nucleic Acids
1 публикация, 3.45%
|
|
|
Indian Journal of Medical Research
1 публикация, 3.45%
|
|
|
International Journal of Infection
1 публикация, 3.45%
|
|
|
Archives of Clinical Infectious Diseases
1 публикация, 3.45%
|
|
|
Médecine et Maladies Infectieuses Formation
1 публикация, 3.45%
|
|
|
VirusDisease
1 публикация, 3.45%
|
|
|
American Journal of Tropical Medicine and Hygiene
1 публикация, 3.45%
|
|
|
Virus Research
1 публикация, 3.45%
|
|
|
Russian Chemical Reviews
1 публикация, 3.45%
|
|
|
New Microbes and New Infections
1 публикация, 3.45%
|
|
|
Therapeutic Advances in Infectious Disease
1 публикация, 3.45%
|
|
|
Clinical Microbiology Reviews
1 публикация, 3.45%
|
|
|
Expert Review of Anti-Infective Therapy
1 публикация, 3.45%
|
|
|
Antiviral Research
1 публикация, 3.45%
|
|
|
Vector-Borne and Zoonotic Diseases
1 публикация, 3.45%
|
|
|
1
2
|
Издатели
|
1
2
3
4
5
6
|
|
|
Elsevier
6 публикаций, 20.69%
|
|
|
Taylor & Francis
4 публикации, 13.79%
|
|
|
Springer Nature
3 публикации, 10.34%
|
|
|
Public Library of Science (PLoS)
2 публикации, 6.9%
|
|
|
Brieflands
2 публикации, 6.9%
|
|
|
SAGE
2 публикации, 6.9%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
2 публикации, 6.9%
|
|
|
Frontiers Media S.A.
1 публикация, 3.45%
|
|
|
MDPI
1 публикация, 3.45%
|
|
|
Scientific Scholar
1 публикация, 3.45%
|
|
|
American Society of Tropical Medicine and Hygiene
1 публикация, 3.45%
|
|
|
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
1 публикация, 3.45%
|
|
|
American Society for Microbiology
1 публикация, 3.45%
|
|
|
1
2
3
4
5
6
|
- Мы не учитываем публикации, у которых нет DOI.
- Статистика публикаций обновляется еженедельно.